Investigation of associations between retinal microvascular parameters and albuminuria in UK Biobank:a cross-sectional case-control study by Paterson, Euan N. et al.
                                                                    
University of Dundee
Investigation of associations between retinal microvascular parameters and
albuminuria in UK Biobank
Paterson, Euan N.; Cardwell, Christopher; MacGillivray, Thomas J.; Trucco, Emanuele;








Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Paterson, E. N., Cardwell, C., MacGillivray, T. J., Trucco, E., Doney, A. S., Foster, P., Maxwell, A. P., McKay, G.
J., & UK Biobank Eye and Vision Consortium (2021). Investigation of associations between retinal microvascular
parameters and albuminuria in UK Biobank: a cross-sectional case-control study. BMC Nephrology, 22, [72].
https://doi.org/10.1186/S12882-021-02273-6
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 20. Apr. 2021
RESEARCH ARTICLE Open Access
Investigation of associations between
retinal microvascular parameters and
albuminuria in UK Biobank: a cross-
sectional case-control study
Euan N. Paterson1, Chris Cardwell1, Thomas J. MacGillivray2, Emanuele Trucco3, Alexander S. Doney4, Paul Foster5,
Alexander P. Maxwell1, Gareth J. McKay1* and on behalf of The UK Biobank Eye and Vision Consortium
Abstract
Background: Associations between microvascular variation and chronic kidney disease (CKD) have been reported
previously. Non-invasive retinal fundus imaging enables evaluation of the microvascular network and may offer
insight to systemic risk associated with CKD.
Methods: Retinal microvascular parameters (fractal dimension [FD] – a measure of the complexity of the vascular
network, tortuosity, and retinal arteriolar and venular calibre) were quantified from macula-centred fundus images
using the Vessel Assessment and Measurement Platform for Images of the REtina (VAMPIRE) version 3.1 (VAMPIRE
group, Universities of Dundee and Edinburgh, Scotland) and assessed for associations with renal damage in a case-
control study nested within the multi-centre UK Biobank cohort study. Participants were designated cases or
controls based on urinary albumin to creatinine ratio (ACR) thresholds. Participants with ACR≥ 3 mg/mmol (ACR
stages A2-A3) were characterised as cases, and those with an ACR < 3 mg/mmol (ACR stage A1) were categorised
as controls. Participants were matched on age, sex and ethnic background.
Results: Lower FD (less extensive microvascular branching) was associated with a small increase in odds of
albuminuria independent of blood pressure, diabetes and other potential confounding variables (odds ratio [OR]
1.18, 95% confidence interval [CI] 1.03–1.34 for arterioles and OR 1.24, CI 1.05–1.47 for venules). Measures of
tortuosity or retinal arteriolar and venular calibre were not significantly associated with ACR.
Conclusions: This study supports previously reported associations between retinal microvascular FD and other
metabolic disturbances affecting the systemic vasculature. The association between retinal microvascular FD and
albuminuria, independent of diabetes and blood pressure, may represent a useful indicator of systemic vascular
damage associated with albuminuria.
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: g.j.mckay@qub.ac.uk
1Centre for Public Health, Institute of Clinical Science, Queen’s University
Belfast, Block B, Royal Hospital, Grosvenor Road, Belfast, Northern Ireland
BT12 6BA
Full list of author information is available at the end of the article
Paterson et al. BMC Nephrology           (2021) 22:72 
https://doi.org/10.1186/s12882-021-02273-6
Background
The retina possesses several characteristics that repre-
sent potential biomarkers for conditions caused by, or
resulting in, microvascular dysfunction, such as chronic
kidney disease (CKD). Indeed, variation in retinal micro-
vascular calibre has been reported in association with a
range of vascular conditions such as coronary heart dis-
ease [1], hypertension [2], stroke [3], and diabetes [4],
highlighting the potential of retinal microvascular pa-
rameters (RMP) for screening systemic microvascular
variation associated with CKD.
The retina has a higher metabolic demand than most
other tissues [5, 6] yet its inner layers are supplied blood
by a particularly sparse microvascular network [6]. As
such, the retinal microvasculature may exhibit particu-
larly responsive structural and physiological adaptations
to reduced blood supply. Furthermore, the microvascula-
ture supplying the inner retinal layers can be imaged
non-invasively using widely available fundus cameras,
allowing the quantification of geometric measures such
as vessel calibre, fractal dimension and tortuosity.
Fractal dimensions (FD) provide a quantification of the
complexity of the vascular network model related to the
iterative growth and branching processes involved in the
formation of the vascular bed. Deviation from ‘normal’
FD and other RMPs may indicate vascular growth pat-
terns associated with certain pathologies [7]. An optimal
vascular geometry provides oxygen and nutrients to cells
with minimal energy expenditure and deviations from
healthy microvascular geometry may result from, or repre-
sent increased susceptibility to, CKD-related vascular im-
pairment [8]. Factors influencing FD, such as impaired
vessel growth, vessel rarefaction and dropout, have been
reported in association with atherosclerosis, hypertension,
Alzheimer’s disease, CKD and diabetes [9]. Retinal micro-
vascular variation in characteristics such as FD and vessel
tortuosity, may reflect systemic changes associated with
cardiovascular disease (CVD) [10, 11], diabetes [12], and
hypertension [10, 13]. Similarly, changes in vessel tortuos-
ity have also been reported in large and small vessels
throughout the body in imaging studies of atherosclerosis,
hypertension and diabetes [14].
In this study, a nested case-control comparison used
participant data from the UK Biobank study (UKBB) [15,
16] to assess associations between retinal microvascular
FD, tortuosity and calibre and urinary albumin creatin-
ine ratio (ACR). The UKBB study is a large, UK-based,
cohort study of middle-aged and older adults undertaken
to improve the prevention, diagnosis and treatment of a
wide range of serious and life-threatening illnesses. The
UKBB study collected data on a large number of vari-
ables including urinary albumin and creatinine and
digital fundus photographs in a subset of participants.
Associations between a range of RMP and renal damage
were evaluated in a nested subset of the UKBB
population.
Methods
Study design and data collection
A cross-sectional, nested case-control study was per-
formed using data from the UKBB population and data
collection has been described previously [15, 16]. Briefly,
UKBB is a multi-centre cohort study that recruited 502,
616 people aged between 40 and 69 years, from the UK
population. Baseline data collection was carried out be-
tween 2006 and 2010. Participants attended assessment
centre visits where interviews were conducted, including
touchscreen and web-based dietary questionnaires, and
measurements were taken of blood pressure and physical
measures including height, weight and waist circumfer-
ence; blood and urine samples were collected. Data re-
lating to eye health (visual acuity and intraocular
pressure etc.) were collected on ~ 112,000 participants.
Digital fundus photographs were available for 67,308
participants. Eye imaging was undertaken at baseline as-
sessment centre visits between December 2009 and July
2010. Data collection and analysis was performed ac-
cording to the principles of the Declaration of Helsinki
under ethical approval from the North West Multi-
Centre Research Ethics committee (06/MRE08/65).
Participant eligibility
Participants were eligible for inclusion in the present
study if eye images were available in addition to urinary
albumin, urinary creatinine, age, sex and ethnic back-
ground data.
Case-control criteria
Participants were selected as cases and controls based
on clinical ACR thresholds calculated from urinary albu-
min and creatinine measurements taken at baseline as-
sessment centre visits. Participants with ACR ≥ 3 mg/
mmol (ACR stages A2-A3) were categorised as cases,
and those with an ACR < 3mg/mmol (ACR stage A1) as
controls.
Participant selection
Of the 67,308 UKBB participants with retinal images,
3499 had ACR ≥ 3 mg/mmol, meeting the inclusion cri-
teria and case designation. A further 20,626 participants
with available data and ACR < 3mg/mmol were eligible
controls (for a flow diagram of the derivation of the
study cohort see Fig. 1) and 3499 age and sex-matched
controls were included in the analyses. Participants were
randomly individually matched without replacement
based on sex and ethnic background categories (White;
Asian or Asian British; Black or Black British; Mixed/
Chinese/Other) with age (age at recruitment) of cases
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matched as closely as possible (age differences up 2 years
were tolerated). Of the 6998 participants included, 1411
(20%) did not have right eye images of sufficient quality
for VAMPIRE image analysis. Of the remaining 5587
(80%) participants, RMP based on the four largest vessels
(including the retinal arcades) were derived for 1890
participants, consisting of 920 cases and 970 controls.
Estimation of glomerular filtration rate (eGFR)
eGFR was calculated using the CKD-EPI equations [17]
based on single serum creatinine (SCr) and cystatin C
(Cys) measurements taken during baseline assessment
centre visits.
Image capture and retinal vessel assessment
Macula-centred digital retinal fundus images were cap-
tured using a Topcon 3D OCT 1000 Mark 2 camera
(Topcon Great Britain Medical Ltd., Berkshire, UK) at base-
line visit. RMP were calculated from fundus images using
the Vessel Assessment and Measurement Platform for Im-
ages of the REtina (VAMPIRE) version 3.1 (VAMPIRE
group, Universities of Dundee and Edinburgh, Scotland).
RMP included the central retinal arteriolar equivalent
(CRAE), central retinal venular equivalent (CRVE), the ar-
teriovenous ratio (AVR), retinal vascular FD and tortuosity.
Trained graders performed image analysis and were blinded
to participant characteristics. Inter-grader reliability was
assessed to ensure consistency of measurements between
graders using intra-class correlation coefficients (ICCs).
ICCs were calculated at intervals and the mean ICCs for
this study were 0.92 (CRAE) and 0.93 (CRVE), above the
thresholds considered “excellent” [18, 19].
Statistical analyses
Statistical analyses were performed using Stata/1C ver-
sion 14.2 (Timberlake Consultants Limited, Richmond
upon Thames, UK). The central tendency and spread of
continuous variables were summarised using the mean
Fig. 1 Study cohort eligibility selection criteria
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and standard deviation (SD) respectively. Categorical
variables were summarised using the frequency and per-
centage. Between-group comparisons were performed
using t-tests for continuous variables and Chi squared
tests for categorical variables.
Logistic regression models were used to test associa-
tions between each RMP (as independent variables) and
ACR category, and, for secondary analyses, prevalence of
eGFR < 60 ml/min/1.73m2 and prevalence of either
ACR > 3mg/mmol and/or eGFR < 60ml/min/1.73m2.
RMP were assessed as z-scores where a single unit
change represented one standard deviation decrease in
the RMP. Three models were considered for each RMP:
Model 1 was unadjusted; Model 2 was adjusted for age,
sex, waist circumference, systolic blood pressure, blood
pressure-lowering medication usage, presence of dia-
betes mellitus, smoking history (as a binary variable, ever
smoked versus never smoked), ethnicity (as a binary
variable, white ethnicity versus non-white ethnicity), and
alcohol consumption (ever versus never). Model 3 in-
cluded variables in model 2, in addition to visual acuity
(assessed using a logarithm of the minimal angle of reso-
lution [logMAR] chart), cornea corrected intraocular
pressure (IOP), and a history of eye surgery (as a binary
variable), to account for the potential effects of magnifi-
cation and retinal abnormalities. Sensitivity analyses ex-
cluded participants with eGFR < 60ml/min/1.73m2 and
additional adjustment for a history of stroke, heart attack
and angina.
Power and sample size calculations
Sample size and power calculations suggested that a
study including 600 cases and 600 controls would have
> 90% power to detect an association between retinal
vessel calibre and CKD of similar magnitude to the asso-
ciation reported by Sabanayagam et al., 2009 [20] (an
odds ratio [OR] of 1.68 for CKD) based on a test for
trend in CKD risk across quarters of the distribution of
retinal vessel calibre.
Results
The summary characteristics for the 1877 participants
(963 cases, and 914 controls) with RMP are shown in
Table 1. The mean age of participants was 58 years (SD
8), mean waist circumference was 93.0 cm (SD 14.8),
mean systolic blood pressure was 146 mmHg (SD 22),
mean eGFR was 88.8 ml/min/1.73m2 (SD 16.0), 1033
(55%) were female, 347 (19%) used blood pressure-
lowering medication, 209 (11%) had diabetes, 1098
(59%) had previously smoked, 1642 (88%) were identified
as white ethnicity, and 1752 (93%) had previously con-
sumed alcohol. Of the participants with ACR ≥ 3mg/
mmol (ACR stages A2-A3), 897 (98%) had moderately
increased ACR between 3 and 30 mg/mmol (equivalent
to ACR stage A2), and 17 (2%) had severely increased
ACR > 30mg/mmol (equivalent to ACR stage A3). Com-
pared to those with ACR stage A1, those with ACR
stages 2–3 had higher systolic blood pressure (143
mmHg (SD 21) vs 150 mmHg (SD 22), p < 0.001), and
intraocular pressure (IOP: 16.41 mmHg (SD 4.78) vs
16.54 mmHg (SD 4.12), p < 0.001), more prevalent use of
blood pressure lowering medication (16% vs 21%, p <
0.001), prevalent diabetes (8% vs 14%, p < 0.001) and
lower retinal arteriolar (1.28 (SD 0.11) vs 1.27 (SD 0.10),
p = 0.01) and venular fractal dimension (1.32 (SD 0.10)
vs 1.3 (SD 0.10), p = 0.01). There were no significant dif-
ferences in eGFR, retinal microvascular calibre (CRAE,
CRVE and AVR) or tortuosity between cases and con-
trols. Comparisons of population characteristics for all
participants that met the inclusion criteria compared to
those in which RMPs were generated, is presented in
Table S1.
Associations between retinal microvascular parameters
and albuminuria categories
Measures of arteriolar and venular calibre (CRAE, CRVE
and AVR) were not significantly associated with ACR
category (ACR stage A1 vs A2-A3) in unadjusted or ad-
justed models (Table 2). Decreased FD (both arteriolar
[FDa] and venular fractal dimension [FDv]) was associ-
ated with greater odds of ACR stages A2-A3. In model
2, adjusted for age, sex, waist circumference, systolic
blood pressure, blood pressure-lowering medication
usage, presence of diabetes mellitus, smoking history,
ethnicity, and alcohol consumption, a single standard
deviation decrease in FDa and FDv were associated with
an increased risk of albuminuria (OR = 1.16, 95% CI
(1.02–1.32) and 1.25, 95% CI (1.06–1.48), respectively),
Table 2, Fig. 2a. Additional adjustment for IOP, logMAR
visual acuity, and a history of eye-surgery did not signifi-
cantly alter the effect size or direction of associations ob-
served. Microvascular tortuosity was not associated with
albuminuria in any of the models tested. Additional ad-
justment for eGFR did not substantially alter the effect
size of the observed association (results not shown).
Similarly, in a sensitivity analysis, that further excluded
control participants with eGFR < 60ml/min/1.73m2
(CKD stages 3–5), did not significantly alter the effect
size of the associations observed (results not shown).
Associations between retinal microvascular parameters
and eGFR < 60ml/min/1.73m2
Associations between RMP and eGFR < 60ml/min/
1.73m2 are shown for eGFR calculated using SCr
(Table 3) and for eGFR calculated using both SCr &
SCys (Table 4 and Fig. 2b). Measures of arteriolar and
venular calibre (CRAE, CRVE and AVR) were not asso-
ciated with eGFR (SCr) < 60 ml/min/1.73m2 in the
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Table 2 Change in odds associated with ACR stages A2-A3 (compared with stage A1) per standard deviation increase in retinal
microvascular parameters
Model 1 p Model 2 p Model 3 p
OR (95% CI) OR (95% CI) OR (95% CI)
CRAE 0.97 (0.87, 1.09) 0.62 0.93 (0.82, 1.04) 0.19 0.94 (0.83, 1.06) 0.31
CRVE 1.01 (0.91, 1.11) 0.87 0.97 (0.88, 1.08) 0.62 0.98 (0.89, 1.09) 0.77
AVR 0.92 (0.81, 1.04) 0.19 0.92 (0.80, 1.05) 0.23 0.92 (0.80, 1.06) 0.23
FDa 1.18 (1.04, 1.33) 0.01 1.16 (1.02, 1.32) 0.02 1.18 (1.03, 1.34) 0.02
FDv 1.24 (1.06, 1.45) 0.01 1.25 (1.06, 1.48) 0.01 1.24 (1.05, 1.47) 0.01
Torta 0.99 (0.90, 1.08) 0.78 0.99 (0.90, 1.09) 0.83 0.98 (0.88, 1.08) 0.62
Tortv 0.96 (0.86, 1.06) 0.37 0.96 (0.87, 1.07) 0.47 0.96 (0.87, 1.06) 0.43
Associations between retinal microvascular parameters (Z scores) vs ACR category. Model 1: unadjusted; Model 2: adjusted for age, sex, waist circumference,
systolic blood pressure, blood pressure-lowering medication usage, presence of diabetes mellitus, smoking history (as a binary variable, ever smoked versus never
smoked), ethnicity (as a binary variable, white ethnicity versus non-white ethnicity), and alcohol consumption (ever versus never); Model 3: adjustment for
variables in model 2 and further adjusted for visual acuity (logMAR), cornea corrected intraocular pressure, and history of eye surgery (as a binary variable)
OR odds ratio, CI confidence interval, CRAE central retina arteriolar equivalent, CRVE central retinal venular equivalent, AVR arteriovenous ratio, FDa/v arteriolar/
venular fractal dimension, Torta/v arteriolar/venular tortuosity
Table 1 Population summary characteristics
All (n = 1877) ACR (n = 963)
< 3mg/mmol
ACR (n = 914)
≥ 3mg/mmol
p
Mean (SD) Mean (SD) Mean (SD)
Age (years) 58 (8) 58 (8) 58 (8) 0.58
Waist circumference (cm) 93 (15) 93 (15) 93 (15) 0.53
Systolic blood pressure (mmHg) 146 (22) 143 (21) 150 (22) < 0.001
eGFR (ml/min/1.73m2) 88.8 (16.0) 88.5 (14.5) 89.1 (17.4) 0.39
IOP (mmHg) 16.48 (4.48) 16.41 (4.78) 16.54 (4.12) < 0.001
LogMAR 0.03 (0.20) 0.03 (0.19) 0.04 (0.20) 0.07
CRAE (px) 22.35 (1.97) 22.33 (2.01) 22.38 (1.93) 0.62
CRVE (px) 28.70 (2.90) 28.71 (2.77) 28.68 (3.02) 0.87
AVR 0.78 (0.10) 0.78 (0.09) 0.78 (0.11) 0.19
FDa 1.28 (0.10) 1.28 (0.11) 1.27 (0.10) 0.01
FDv 1.31 (0.10) 1.32 (0.10) 1.30 (0.10) 0.01
Torta 3.00+ (9.00+) 3.00+ (9.00+) 3.00+ (9.00+) 0.78
Tortv 2.00+ (4.00+) 2.00+ (5.00+) 2.00+ (4.00+) 0.36
Number (%) Number (%) Number (%) p
ACR stage A2 897 (48) 0 (0) 897 (98) < 0.001
ACR stage A3 17 (1) 0 (0) 17 (2) < 0.001
eGFR < 60 ml/min/1.73m2 65 (4) 21 (2) 44 (5) 0.001
Sex (Female) 1033 (55) 521 (54) 512 (56) 0.4
Blood pressure-lowering medication usage 347 (19) 152 (16) 195 (21) < 0.001
Diabetes mellitus 209 (11) 78 (8) 131 (14) < 0.001
Ever smoked 1098 (59) 543 (57) 555 (61) 0.06
White ethnicity 1642 (88) 846 (88) 796 (87) 0.58
Ever consumed alcohol 1752 (93) 905 (94) 847 (93) 0.22
Ever eye surgery 127 (7) 63 (7) 64 (7) 0.69
SD standard deviation, eGFR Estimated glomerular filtration rate, IOP Intraocular pressure, LogMAR visual acuity assessed using a Logarithm of the Minimum Angle
of Resolution chart, CRAE central retina arteriolar equivalent, CRVE central retinal venular equivalent, px pixels, AVR arteriovenous ratio, FDa/v arteriolar/venular
fractal dimension, Torta/v arteriolar/venular tortuosity
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unadjusted or adjusted model 2. Following adjustment
for IOP, visual acuity and history of eye surgery, nar-
rower retinal arterioles were significantly associated with
increased odds of eGFR (SCr) < 60 ml/min/1.73m2 (OR =
1.63, 95% CI: 1.15, 2.31). However, calculation of eGFR
based on both SCr and SCys, identified no significant as-
sociations with arteriolar or venular calibre. Lower FDa
was also significantly associated with eGFR < 60ml/min/
1.73m2 in all models, regardless of eGFR estimation ap-
proach. In fully adjusted models, a single standard devi-
ation decrease in FDa was associated with and OR = 1.68
(1.15, 2.45) for eGFR (combined SCr and SCys) < 60ml/
min/1.73m2 (CKD stages 3–5), Table 4 and Fig. 2b.
Microvascular tortuosity was not associated with CKD
stages 3–5 in any of the models tested. Additional sensi-
tivity analyses categorising participants by eGFR < 60ml/
min/1.73m2 based on the CKD-EPI equation for SCys
only, showed little difference in effect to the findings re-
ported for the combined SCr and SCys equation.
Associations between retinal microvascular parameters
and either ACR > 3mg/mmol or eGFR < 60ml/min/1.73m2
Associations between RMP and ACR > 3mg/mmol or
eGFR < 60ml/min/1.73m2 (SCr & SCys) are shown in
Table 5. Measures of microvascular calibre (CRAE,
CRVE and AVR) were not significantly associated with
ACR > 3mg/mmol or eGFR < 60ml/min/1.73m2 in any
of the models tested. A single SD decrease in FD (both
Fig. 2 Associations between retinal microvascular parameters and measures of renal function and damage. Associations between retinal
microvascular parameters (Z scores) and a: ACR > 3 mg/mmol; b: eGFR < 60 ml/min/1.73m2 (combined CKD-EPI for both serum creatinine and
serum cystatin C); c: ACR > 3mg/mmol and/or eGFR < 60 ml/min/1.73m2 combined CKD-EPI for both serum creatinine and serum cystatin C), for
Model 2 (adjusted for age, sex, waist circumference, systolic blood pressure, blood pressure-lowering medication usage, presence of diabetes
mellitus, smoking history (as a binary variable, ever smoked versus never smoked), ethnicity (as a binary variable, white ethnicity versus non-white
ethnicity), and alcohol consumption (ever versus never)).*Association significant at the p < 0.05 level. ACR: albumin to creatinine ratio; CRAE:
central retina arteriolar equivalent; CRVE: central retinal venular equivalent; AVR: arteriovenous ratio; FDa/v: arteriolar/venular fractal dimension;
Torta/v: arteriolar/venular tortuosity. Bars indicate 95% confidence intervals
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FDa and FDv) was significantly associated with ACR > 3
mg/mmol or eGFR < 60ml/min/1.73m2 in all models
tested (Table 5, Fig. 2c). In the fully adjusted model, a
single SD decrease in FDa and FDv was significantly as-
sociated with an increase in odds = 1.22, 95% CI (1.06–
1.39) and 1.26, 95% CI (1.06–1.50) respectively. Micro-
vascular tortuosity was not associated with ACR > 3mg/
mmol or eGFR < 60ml/min/1.73m2 in any of the models
tested. Further adjustment for stroke, heart attack and
angina in a sensitivity analysis did not significantly alter
the findings reported (data not shown).
Discussion
In this nested case-control study of UKBB participants,
we evaluated associations between RMP and albumin-
uria (ACR > 3mg/mmol) and eGFR < 60ml/min/1.73m2
in a secondary analysis. Reduced FD (lower geometric
complexity of the vascular network) was associated with
moderately increased odds of albuminuria independent
of blood pressure, diabetes and other potential
confounding variables. Given the previously reported as-
sociations between retinal microvascular FD and other
metabolic and barometric disturbances affecting the sys-
temic vasculature [10–12], and the associations identi-
fied in this study independent of diabetes and blood
pressure, retinal microvascular FD may be a useful indi-
cator of systemic vascular damage associated with albu-
minuria. Lower arteriolar FD was also associated with a
moderately greater risk of eGFR < 60ml/min/1.73m2.
This study returned little evidence that measures of ret-
inal microvascular calibre (CRAE, CRVE, and AVR) or
tortuosity were associated with ACR.
Normal organ development manifests through optimal
microvascular branching to maximise oxygen and nutri-
ent supply with minimal energy expenditure [7, 8].
Given the microvascular damage that contributes to
CKD [21], retinal imaging may provide opportunistic
non-invasive assessment of the microvascular variation
associated with CKD risk. However, CKD also results in
systemic microvascular damage due to calcification [22,
Table 3 Associations between retinal microvascular parameters (Z scores) vs eGFR (SCr) < 60 ml/min/1.73m2
Model 1 p Model 2 p Model 3 p
OR (95% CI) OR (95% CI) OR (95% CI)
CRAE 1.30 (0.95, 1.78) 0.10 1.37 (0.99, 1.91) 0.06 1.63 (1.15, 2.31) 0.01
CRVE 1.25 (0.94, 1.67) 0.13 1.25 (0.91, 1.70) 0.17 1.24 (0.89, 1.75) 0.21
AVR 1.01 (0.67, 1.52) 0.98 1.07 (0.68, 1.70) 0.76 1.30 (0.79, 2.15) 0.31
FDa 1.50 (1.09, 2.08) 0.01 1.57 (1.11, 2.24) 0.01 1.57 (1.10, 2.24) 0.01
FDv 1.28 (0.82, 2.01) 0.28 1.20 (0.72, 1.99) 0.48 1.15 (0.68, 1.96) 0.60
Torta 0.93 (0.77, 1.12) 0.43 0.93 (0.73, 1.17) 0.53 0.90 (0.72, 1.12) 0.35
Tortv 1.85 (0.74, 4.62) 0.19 1.73 (0.72, 4.18) 0.22 1.65 (0.66, 4.15) 0.28
Associations between retinal microvascular parameters (Z scores) vs eGFR < 60ml/min/1.73m2 based on serum creatinine. Model 1: unadjusted; Model 2: adjusted
for age, sex, waist circumference, systolic blood pressure, blood pressure-lowering medication usage, presence of diabetes mellitus, smoking history (as a binary
variable, ever smoked versus never smoked), ethnicity (as a binary variable, white ethnicity versus non-white ethnicity), and alcohol consumption (ever versus
never); Model 3: adjustment for variables in model 2 and further adjusted for visual acuity (logMAR), cornea corrected intraocular pressure, and history of eye
surgery (as a binary variable)
OR odds ratio, CI confidence interval, CRAE central retina arteriolar equivalent, CRVE central retinal venular equivalent, AVR arteriovenous ratio, FDa/v arteriolar/
venular fractal dimension, Torta/v arteriolar/venular tortuosity
Table 4 Associations between retinal microvascular parameters (Z scores) vs eGFR (SCr & SCys) < 60 ml/min/1.73m2
Model 1 p Model 2 p Model 3 p
OR (95% CI) OR (95% CI) OR (95% CI)
CRAE 1.20 (0.88, 1.62) 0.25 1.17 (0.84, 1.62) 0.36 1.29 (0.91, 1.82) 0.15
CRVE 1.10 (0.83, 1.47) 0.49 1.10 (0.81, 1.50) 0.55 1.11 (0.79, 1.54) 0.55
AVR 1.02 (0.68, 1.52) 0.94 0.98 (0.61, 1.57) 0.94 1.08 (0.65, 1.80) 0.77
FDa 1.50 (1.08, 2.09) 0.02 1.65 (1.13, 2.41) 0.01 1.68 (1.15, 2.45) 0.01
FDv 1.35 (0.87, 2.09) 0.18 1.27 (0.77, 2.09) 0.35 1.17 (0.69, 1.99) 0.55
Torta 0.90 (0.77, 1.05) 0.20 0.90 (0.74, 1.10) 0.29 0.89 (0.73, 1.07) 0.22
Tortv 1.94 (0.77, 4.88) 0.16 1.97 (0.75, 5.21) 0.17 2.05 (0.72, 5.83) 0.18
Associations between retinal microvascular parameters (Z scores) vs eGFR < 60ml/min/1.73m2 based on serum creatinine and cystatin C. Model 1: unadjusted;
Model 2: adjusted for age, sex, waist circumference, systolic blood pressure, blood pressure-lowering medication usage, presence of diabetes mellitus, smoking
history (as a binary variable, ever smoked versus never smoked), ethnicity (as a binary variable, white ethnicity versus non-white ethnicity), and alcohol
consumption (ever versus never); Model 3: adjustment for variables in model 2 and further adjusted for visual acuity (logMAR), cornea corrected intraocular
pressure, and history of eye surgery (as a binary variable). OR: odds ratio; CI: confidence interval
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23], altered blood pressure, and endothelial dysfunction
[24–26]. Indeed, CKD is associated with an increased
risk of overt microvascular changes in the retina, such as
retinopathy [27, 28], although this association may arise
from the effects of shared risk factors [29]. Therefore,
there is an issue of reverse causality whereby FD may be
associated with both the causes and effects of CKD. Fur-
thermore, the possibility of retro-causality exists
whereby, vascular effects of renal dysfunction may mani-
fest early in the disease process [30–32], with sub-
clinical reductions in renal function, which may also re-
sult in detectible variation in RMPs prior to clinical
CKD diagnosis. Indeed, the retina is particularly sensitive
to alterations in oxygen supply as a result of its high
oxygen demand [33], and retinal microvascular fractals
are also significantly altered in response to other condi-
tions involving vascular and neuronal health [10–12,
21–23]. Therefore, FD may prove sufficiently sensitive to
serve as an indicator of microvascular damage. Never-
theless, the accuracy of automated estimates of FD from
retinal images remains a work in progress [34–36].
Few studies have previously assessed associations be-
tween ACR and retinal microvascular tortuosity or FD.
In the Singapore Malay Eye Study, greater FD was asso-
ciated with reduced likelihood (OR 0.76) of albuminuria
in adults of Malay ethnicity [37]. Similarly, the present
study found associations of similar strength and direc-
tion in a population of largely European descent. In
addition, The Singapore Malay Eye Study also reported
no significant associations between arteriolar or venular
tortuosity and ACR [37].
Retinal microvascular calibre has been previously pro-
posed as a potential biomarker for CKD from data gen-
erated from several population-based studies but the
findings reported have been inconsistent. The findings
of the present study support a previous lack of reported
association between CRAE and ACR [37–40], in contrast
to previous reported associations between narrower ret-
inal arterioles and higher ACR [41–46] or urinary albu-
min excretion [47]. Similarly, consistent with the present
analyses, most studies also found no association between
venular calibre and ACR [37, 38, 41, 43, 44], although
some reported associations between narrower venular
calibre and higher urinary albumin excretion [47] and
conversely, lower ACR [39, 40].
This study had several strengths in providing evidence
of association between renal health and FD in a large
well-characterised population-based study. Calculation
of eGFR was undertaken using two methods: the CKD-
EPI for SCr and the CKD-EPI equation for SCr and SCys
[17]. The use of SCys offers improved sensitivity over
eGFR based on SCr alone [48]. Moreover, although
eGFR calculation based on the CKD-EPI equation for
SCr is more commonly used in current clinical practice,
a recent study using data from the UKBB has shown that
eGFR calculated using the CKD-EPI equation for SCys
better predicts the main problems associated with CKD
(CVD, CVD-related mortality and renal failure) [49].
The UKBB dataset allowed us to compare associations
using eGFR calculation based on eGFR and SCys. Add-
itional analyses categorising participants by eGFR < 60
ml/min/1.73m2 based on the CKD-EPI equation for
SCys showed no substantive difference to associations
using the combined SCr and SCys equation (data not
shown). UKBB was a well-characterised study that en-
abled consideration of a wide range of potential con-
founders representative of the UK population. For
example, to account for the possibility that albuminuria
and reduced renal function may represent manifestations
of vascular dysfunction, sensitivity analyses were carried
out with additional adjustment for covariates related to
atherosclerotic vascular disease (specifically a history of
Table 5 Associations between retinal microvascular parameters (Z scores) vs CKD status based on ACR > 3mg/mmol and/or eGFR <
60ml/min/1.73m2 (SCr & SCys)
Model 1 p Model 2 p Model 3 p
OR (95% CI) OR (95% CI) OR (95% CI)
CRAE 1.01 (0.90, 1.13) 0.88 0.97 (0.86, 1.09) 0.59 0.98 (0.87, 1.11) 0.79
CRVE 1.03 (0.93, 1.14) 0.59 0.99 (0.89, 1.10) 0.90 1.01 (0.90, 1.12) 0.92
AVR 0.92 (0.81, 1.05) 0.21 0.93 (0.80, 1.06) 0.27 0.93 (0.80, 1.07) 0.29
FDa 1.22 (1.07, 1.39) 0.003 1.20 (1.05, 1.37) 0.01 1.22 (1.06, 1.39) 0.01
FDv 1.27 (1.08, 1.49) 0.004 1.28 (1.08, 1.52) 0.01 1.26 (1.06, 1.50) 0.01
Torta 0.99 (0.90, 1.09) 0.85 1.00 (0.90, 1.10) 0.92 0.98 (0.89, 1.08) 0.69
Tortv 0.97 (0.88, 1.07) 0.52 0.98 (0.88, 1.08) 0.65 0.98 (0.88, 1.08) 0.63
Associations between retinal microvascular parameters (Z scores) vs CKD status based on ACR > 3mg/mmol and/or eGFR < 60ml/min/1.73m2 (based on serum
creatinine and serum cystatin C). Model 1: unadjusted; Model 2: adjusted for age, sex, waist circumference, systolic blood pressure, blood pressure-lowering
medication usage, presence of diabetes mellitus, smoking history (as a binary variable, ever smoked versus never smoked), ethnicity (as a binary variable, white
ethnicity versus non-white ethnicity), and alcohol consumption (ever versus never); Model 3: adjustment for variables in model 2 and further adjusted for visual
acuity (logMAR), cornea corrected intraocular pressure, and history of eye surgery (as a binary variable)
OR odds ratio, CI confidence interval
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stroke, heart attack and angina), although this failed to
identify any additional significant findings beyond those
reported in the current analyses. CRAE and CRVE are
commonly estimated using microns as the unit of meas-
urement. However, true quantification of calibre using
fundus images is challenging due to differences in eye
axial length, image magnification, accurate models of the
optical path and due to a lack of accessible fiducial
markers in the eye to facilitate calibration. Instead, soft-
ware packages commonly use standardised approxima-
tions of optic disc diameter as a reference to convert
pixels into microns, which leads to uncertainty in vessel
calibre estimates. In contrast, VAMPIRE measures retinal
microvascular calibre in pixels, reducing measurement
error. Furthermore, statistical approaches based on stand-
ard deviation changes (Z scores) in RMP enable compari-
sons between studies that may vary by unit measures.
There were several limitations in our study. UKBB had
lower than expected prevalence of several common dis-
eases and may represent a “worried-well” within the UK
and not entirely reflective of the population as a whole.
In addition, ACR and eGFR were based on single mea-
sures of urinary albumin, urinary creatinine, and serum
creatinine that differs from clinical definitions based on
two measurements captured at least 3 months apart in-
dicative of persistent albuminuria or reduced eGFR.
Therefore, associations reported in this study may differ
somewhat from those representative of clinical popula-
tions. Moreover, cases and controls were selected on the
basis of ACR values and therefore secondary analyses
between eGFR and RMP may not be entirely representa-
tive of the general population which may have higher
levels of multiple morbidity. However, eGFR did not dif-
fer significantly between cases and controls, and key
confounding influences (such as diabetes and blood
pressure) were considered within adjusted models.
There was a high rate of image rejection in our study
as a consequence of image quality including focus, con-
trast, positioning, eyelid and/or eye-lashes and excessive
lighting (see Figure S1). Acquisition of UKBB vision data
was time-limited and involved the collection of macula-
centred fundus images only. Studies on the suitability of
UKBB retinal images for semi-automated analysis have
reported similar rejection rates [50, 51]. Software pack-
ages such as VAMPIRE provide improved sensitivity on
optic disc centred images which capture a greater
amount of the retinal microvasculature [52]. Further-
more, CRAE and CRVE are normally estimated using
the six largest vessels, but macula-centred images typic-
ally exclude large vessels nasal to the optic disc. To fa-
cilitate measurement of RMPs in macula centred images,
only those with at least four of the big six vessels, in-
cluding the vessels of the retinal arcade (the largest ret-
inal vessels) situated temporally to the optic disc, were
included for analysis. As such, the absolute RMPs quan-
tified as part of the current study may be limited in dir-
ect comparisons with those from other studies.
Nevertheless, despite the high image rejection rate, the
number of participants included in the study (920 cases
and 970 controls) exceeded the numbers required to
achieve statistical power.
Image rejection was slightly more common for older,
non-white participants with a history of eye-surgery,
higher LogMAR and lower IOP (see Table S1). Although
significant, these differences are unlikely to influence the
generalisability of our findings due to the small size of
the differences detected in this large population. Mean
age, for example, differed by 1 year, and a 3% difference
in the use of blood pressure-lowering medication in
cases was the largest difference in any categorical
variable.
There are a range of factors that likely influence FD
estimates and limit comparisons between studies and
measurement algorithms. Variation in microvessel detec-
tion, measurement zones, automated segmentation pro-
tocols and thresholds used to create binary maps, may
potentially confound associations between disease states
and FD [34]. Moreover, FD values produced by various
software packages may be sensitive to the use of differ-
ent fundus cameras [34]. Although UKBB is a multicen-
tre study, all images were captured using Topcon 3D
OCT 1000 Mark 2 cameras.
Fundus images are routinely collected as part of dia-
betic eye screening and are a non-invasive imaging mo-
dality allowing the measurement of tissue changes
associated with disease. The present study made use of
semi-automated retinal vessel analysis. Recently a fully
automated deep learning algorithm has been reported
which classifies individuals as having CKD or no CKD
based on macula-centred retinal images [53]. Other deep
learning algorithms have been found to compare
favourably to manual expert-led classification of images
for conditions such as skin cancers [54] breast cancer
[55] and diabetic retinopathy [56]. Using only fundus
images as input, the performance of this algorithm com-
pared favourably to CKD prediction equations based on
traditional risk factors, and maintained similar perform-
ance in subgroups of participants with diabetes and
hypertension [53]. Moreover, inclusion of addition of
risk factors to the algorithm only marginally improved
sensitivity and specificity [53]. The algorithm derived in-
formation from the entire fundus images rather than be-
ing limited to characteristics of the retinal vasculature
but nevertheless made use of key features such as venu-
lar dilation, vessel rarefaction and changes associated
with retinopathy [53]. This indicates some overlap with
the present findings where vessel rarefaction (reduced
FD) was associated with a greater risk of CKD.
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Conclusions
Overall, the findings from this case-control study of par-
ticipants with healthy versus unhealthy ACR indicates
that reduced retinal microvascular FD, i.e. sparser retinal
microvascular networks, are associated with albuminuria
and lower eGFR in a predominantly white population.
No evidence was found for associations between ACR or
eGFR and measures of retinal microvascular calibre and
tortuosity.
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